RNA chaperones are gaining traction as a way to keep the RNA-binding protein TDP-43 in its physiological conformation and prevent it from clumping up. Now, scientists offer a way to make these ...
Alzheimerologists, it is time to update your GWAS catalogue—again. In June 3 Nature Genetics, a staggering 508 scientists (yes, we counted) from across the United States and Europe, led by Céline ...
When the RNA-binding protein TDP-43 absconds from the nucleus, splicing chaos ensues and neuronal function gets disrupted in ways scientists are still cataloguing. Now on this list: synaptic ...
Education Comments Synapses Suffer When Splicing Goes Awry in TDP-43 Proteinopathy 03 Jun 2026 ...
Associate Professor Buck Institute for Research on Aging https://www.buckinstitute.org/lab/tracy-lab/ ...
Vishakha Trivedi Contact Information Vishakha Trivedi India ...
Low dose interleukin 2 is being tested as an immunomodulatory approach in neurodegenerative diseases. It increases the number and activity of regulatory T cells (Tregs) that suppress inflammation. At ...
I received my BS from Cornell University in 2001, did post-baccalaureate studies at Columbia, and then received my MD from Mt. Sinai School of Medicine in 2008. I then did two years of general surgery ...
Professional Information Graduate Student in Mathematics and NeurosurgeonMississippi State University Education BS biochemistry Tulane MD Tulane ...
Education The University of Western Australia PhD, Molecular Biology Murdoch University, Western Australia Bachelor of Science, Biotechnology ...
Score another one for amyloid immunotherapy. The anti-pyroglutamated amyloid antibody donanemab has posted positive top-line results in the Phase 3 Trailblazer-Alz2 study, according to an Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results